OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
May 03, 2022
Among the topics discussed at Pharm Exec’s recent RWE roundtable are how the pandemic has served to validate the use of RWE/RWD; the most important features of a real-world data set; and key considerations when selecting an RWD partner.
March 22, 2022
In this segment, executives discuss the need to adjust to virtual and in-person, face-to-face interactions with both internal and external stakeholders.
Among the topic discussed at the roundtable were ways to address acquiring and attracting new talent, as well as retaining talent in the post-COVID workforce.
In this segment, leaders suggest areas to continue building on lessons learned during COVID, including the pharma industry as a tech destination and impact on patient outcomes.
In this roundtable, executives discuss continued manufacturing and supply challenges, as well as the need for back-up plans.
February 04, 2022
In this segment, members of the panel discuss talent and culture, what to expect from the workforce of the future, and how to develop it in the next 5-10 years.
In this segment, members of the panel discuss consolidation of practices and managing business from a field perspective focusing on understanding the needs and insights of customer groups. Where is it needed?
In this two-part segment, members of the panel discuss how the tradition pharma sales force has entered a phase in which they have to evolve, but what is the digital/in-person balance and how will the sales role change?
In this segment, members of the panel discuss how to make medicine more accessible to the broader population. And how does the industry address affordability?